Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomized, double-blind, phase 3 trial.

Butts C;Socinski M A;Mitchell P L;Thatcher N;Havel L;Krzakowski M;Nawrocki S;Ciuleanu T E;Bosquée L;Trigo J M;Spira A;Tremblay L;Nyman J;Ramlau R;Johansson G W;Ellis P;Gladkov O;Rodrigues Pereira J;Eberhardt W E E;Helwig C;Schröder A;Shepherd F;Santoro A

2014-01-01